Sunday, November 8, 2026

USD/CNH Bearish By 1% In The Last 10 Sessions

USD/CNH Bearish By 1% In The Last 10 Sessions

(VIANEWS) - USD/CNH (USDCNH) has been up by 1.6% for the last 10 sessions. At 07:07 EST on Wednesday, 20 March, USD/CNH (USDCNH) is $7.21.

USD/CNH's yearly highs and lows, it's 0.036% up from its 52-week low and 0.053% down from its 52-week high.

News about

  • According to FXStreet on Monday, 18 March, "At the time of writing, USD/JPY is consolidating its latest uptick near 149.15, adding 0.09% so far."
  • Any big hawkish surprise from fed chair powell could push usd/jpy beyond its 2022 high at 151.90 – TDS. According to FXStreet on Tuesday, 19 March, "USD/JPY is now hostage to the FOMC decision on Wednesday and any big hawkish surprise from Powell could push USD/JPY beyond its 2022 high at 151.90 which may invoke some strong verbal interventions from the MoF."
  • According to FXStreet on Tuesday, 19 March, "From a technical perspective, the USD/JPY pair is holding above the 61.8% Fibonacci retracement level of the February-March downfall and seems poised to climb further. ", "Apart from this, a modest US Dollar (USD) strength, bolstered by reduced bets for steep interest rate cuts by the Federal Reserve (Fed), lifts the USD/JPY pair closer to mid-149.00s."
  • Usd/jpy holds strength above 149.00 ahead of boj-fed policy decisions. According to FXStreet on Monday, 18 March, "The USD/JPY pair exhibits strength above the crucial support of 149.00 in the early New York session. "
  • According to FXStreet on Monday, 18 March, "Given that oscillators on the daily chart have just started gaining positive traction, the USD/JPY pair seems poised to appreciate further towards the 149.75-149.80 horizontal resistance. ", "This is followed by the 148.00 round figure, below which the USD/JPY pair could accelerate the slide towards the 100-day Simple Moving Average (SMA), currently pegged near the 147.65 region. "

More news about USD/CNH (USDCNH).

ViaNews Editorial Team

Via News Editorial Team delivers comprehensive financial news coverage and market analysis from journalists around the world. Our team specializes in data journalism and in-depth reporting on stock markets, business developments, and economic trends.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Q4 2026 Biotech Catalyst Season: Regulatory Deadlines and Data Readouts Against Cost Discipline and Slipping Timelines
From late October 2026 to January 2027, mid-cap biotechs cluster pivotal data presentations (ESMO, AHA, AASLD), FDA decision dates (ivonescimab BLA on 2026-11-14, lorundrostat on 2026-12-22) and Q3 earnings. Alongside these, several companies are managing capital: lowering R&D and SG&A guidance, pushing clinical milestones into 2027, authorizing a $400M buyback, and pursuing a delisting. Late-stage programs in oncology, hepatitis delta, hypertension and women's health look near commercial inflection, while cost cuts and delays point to uneven balance-sheet strength.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Ford Motor Company
Both facts give cash for Ford Motor Company at the same point in time (2025-12-31; FY 2025 year-end and Q4 2025 year-end are the same date). Both are labelled USD, but the values are 23,356,000,000 and 23.356, which cannot both be true in USD. The two numbers agree once the second is read as billions (23.356 bn = 23,356,000,000), so the economic content is consistent and the conflict is a unit/scale error in the Q4 2025 record. The period is not the reason for the conflict: a Q4 and an FY figure at the same year-end date should match.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,996
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,996 facts checked against source5,552 source documents archived
Query this data → isubstrate.com